Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting bone loss
US5639765A · kind A · utility
7Cited by
4References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 17, 1995 |
| Grant date | Jun 17, 1997 |
| Priority date | — |
| Expiry date | Jan 17, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention herein relates to a method of inhibiting bone resorption by administering a therapeutically effective amount of a compound having the following formula ##STR1## or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.